These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9412539)

  • 21. [Pathophysiology of chronic heart failure].
    Weil J; Schunkert H
    Clin Res Cardiol; 2006; 95 Suppl 4():1-15; quiz 16-7. PubMed ID: 16598604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombospondins in the transition from myocardial infarction to heart failure.
    Kirk JA; Cingolani OH
    J Mol Cell Cardiol; 2016 Jan; 90():102-10. PubMed ID: 26686988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix modulation and heart failure: new concepts question old beliefs.
    Deschamps AM; Spinale FG
    Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH
    Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and molecular aspects of contractile dysfunction in heart failure.
    Mittmann C; Eschenhagen T; Scholz H
    Cardiovasc Res; 1998 Aug; 39(2):267-75. PubMed ID: 9798511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.
    Li B; Chi RF; Qin FZ; Guo XF
    Exp Physiol; 2016 Aug; 101(8):1050-63. PubMed ID: 27219474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiological basis of heart failure].
    Pieske B; Hasenfuss G
    Ther Umsch; 2000 May; 57(5):284-92. PubMed ID: 10859987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress during myocardial ischaemia and heart failure.
    Ferrari R; Agnoletti L; Comini L; Gaia G; Bachetti T; Cargnoni A; Ceconi C; Curello S; Visioli O
    Eur Heart J; 1998 Feb; 19 Suppl B():B2-11. PubMed ID: 9519346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy.
    Mollnau H; Oelze M; August M; Wendt M; Daiber A; Schulz E; Baldus S; Kleschyov AL; Materne A; Wenzel P; Hink U; Nickenig G; Fleming I; Münzel T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2554-9. PubMed ID: 16224052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local contractile and growth modulators in the myocardium.
    Dzau VJ
    Clin Cardiol; 1993 May; 16(5 Suppl 2):II5-9. PubMed ID: 8504588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H; Kinugawa S; Matsushima S
    Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is heart failure an abnormality of myocardial cell growth?
    Katz AM
    Cardiology; 1990; 77(5):346-56. PubMed ID: 2073654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial collagen matrix remodelling in arterial hypertension.
    Brilla CG; Maisch B; Weber KT
    Eur Heart J; 1992 Sep; 13 Suppl D():24-32. PubMed ID: 1396856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology of heart failure today].
    Böhm M
    Herz; 2002 Mar; 27(2):75-91. PubMed ID: 12025466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.